Cheng, Y.-T.; Chang, F.-L.; Li, P.-H.; Lu, W.-C.; Chiu, C.-S.
Assessing the Suitability of CHA2DS2-VASc for Predicting Adverse Limb Events and Cardiovascular Outcomes in Peripheral Artery Disease Patients with Percutaneous Transluminal Angioplasty: A Retrospective Cohort Study. Biomedicines 2024, 12, 1374.
https://doi.org/10.3390/biomedicines12061374
AMA Style
Cheng Y-T, Chang F-L, Li P-H, Lu W-C, Chiu C-S.
Assessing the Suitability of CHA2DS2-VASc for Predicting Adverse Limb Events and Cardiovascular Outcomes in Peripheral Artery Disease Patients with Percutaneous Transluminal Angioplasty: A Retrospective Cohort Study. Biomedicines. 2024; 12(6):1374.
https://doi.org/10.3390/biomedicines12061374
Chicago/Turabian Style
Cheng, Yu-Tsung, Fu-Lan Chang, Po-Hsien Li, Wen-Chien Lu, and Chien-Shan Chiu.
2024. "Assessing the Suitability of CHA2DS2-VASc for Predicting Adverse Limb Events and Cardiovascular Outcomes in Peripheral Artery Disease Patients with Percutaneous Transluminal Angioplasty: A Retrospective Cohort Study" Biomedicines 12, no. 6: 1374.
https://doi.org/10.3390/biomedicines12061374
APA Style
Cheng, Y.-T., Chang, F.-L., Li, P.-H., Lu, W.-C., & Chiu, C.-S.
(2024). Assessing the Suitability of CHA2DS2-VASc for Predicting Adverse Limb Events and Cardiovascular Outcomes in Peripheral Artery Disease Patients with Percutaneous Transluminal Angioplasty: A Retrospective Cohort Study. Biomedicines, 12(6), 1374.
https://doi.org/10.3390/biomedicines12061374
